These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30715799)

  • 21. Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1.
    Li X; Qiu J; Pan M; Zheng D; Su Y; Wei M; Kong X; Sun W; Zhu J
    Int J Clin Exp Pathol; 2015; 8(9):10743-51. PubMed ID: 26617785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of calcyclin-binding protein against pulmonary vascular remodeling in flow-associated pulmonary arterial hypertension.
    Zhou J; Li F; Yang Y
    Respir Res; 2022 Aug; 23(1):223. PubMed ID: 36042446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
    Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
    J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Galectin-3 aggravates pulmonary arterial hypertension via immunomodulation in congenital heart disease.
    Shen Q; Chen W; Liu J; Liang Q
    Life Sci; 2019 Sep; 232():116546. PubMed ID: 31176777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic Evaluation of Children with Persistent or Recurrent Pulmonary Arterial Hypertension Following Complete Repair of Congenital Heart Disease.
    Latus H; Wagner I; Ostermayer S; Kerst G; Kreuder J; Schranz D; Apitz C
    Pediatr Cardiol; 2017 Oct; 38(7):1342-1349. PubMed ID: 28681131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CPT1 regulates the proliferation of pulmonary artery smooth muscle cells through the AMPK-p53-p21 pathway in pulmonary arterial hypertension.
    Zhuang W; Lian G; Huang B; Du A; Gong J; Xiao G; Xu C; Wang H; Xie L
    Mol Cell Biochem; 2019 May; 455(1-2):169-183. PubMed ID: 30511343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cysteine-rich 61 (Cyr61) upregulated in pulmonary arterial hypertension promotes the proliferation of pulmonary artery smooth muscle cells.
    Gao L; Fan Y; Hao Y; Yuan P; Liu D; Jing Z; Zhang Z
    Int J Med Sci; 2017; 14(9):820-828. PubMed ID: 28824319
    [No Abstract]   [Full Text] [Related]  

  • 28. Ovine Models of Congenital Heart Disease and the Consequences of Hemodynamic Alterations for Pulmonary Artery Remodeling.
    Johnson Kameny R; Datar SA; Boehme JB; Morris C; Zhu T; Goudy BD; Johnson EG; Galambos C; Raff GW; Sun X; Wang T; Chiacchia SR; Lu Q; Black SM; Maltepe E; Fineman JR
    Am J Respir Cell Mol Biol; 2019 May; 60(5):503-514. PubMed ID: 30620615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
    Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
    Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic deletion of CMG2 exacerbates systemic-to-pulmonary shunt-induced pulmonary arterial hypertension.
    Meng L; Yuan W; Chi H; Han R; Zhang Y; Pan X; Meng J; Liu Y; Song J; Zhong J; Liu X
    FASEB J; 2021 Apr; 35(4):e21421. PubMed ID: 33749907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of calcium-activated chloride channel to elevated pulmonary artery pressure in pulmonary arterial hypertension induced by high pulmonary blood flow.
    Wang K; Chen C; Ma J; Lao J; Pang Y
    Int J Clin Exp Pathol; 2015; 8(1):146-54. PubMed ID: 25755701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
    Hautefort A; Mendes-Ferreira P; Sabourin J; Manaud G; Bertero T; Rucker-Martin C; Riou M; Adão R; Manoury B; Lambert M; Boet A; Lecerf F; Domergue V; Brás-Silva C; Gomez AM; Montani D; Girerd B; Humbert M; Antigny F; Perros F
    Circulation; 2019 Feb; 139(7):932-948. PubMed ID: 30586714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contemporary survival of patients with pulmonary arterial hypertension and congenital systemic to pulmonary shunts.
    Vijarnsorn C; Durongpisitkul K; Chungsomprasong P; Bositthipichet D; Ketsara S; Titaram Y; Chanthong P; Kanjanauthai S; Soongswang J
    PLoS One; 2018; 13(4):e0195092. PubMed ID: 29664959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Original rat model of high kinetic unilateral pulmonary hypertension surgically induced by combined surgery.
    Meng L; Liu X; Zheng Z; Li J; Meng J; Wei Y; Hu S
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1220-1226.e1. PubMed ID: 23395098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LRP1 Deficiency in Vascular SMC Leads to Pulmonary Arterial Hypertension That Is Reversed by PPARγ Activation.
    Calvier L; Boucher P; Herz J; Hansmann G
    Circ Res; 2019 Jun; 124(12):1778-1785. PubMed ID: 31023188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HMGB1/TLR4 promotes hypoxic pulmonary hypertension via suppressing BMPR2 signaling.
    Wang J; Tian XT; Peng Z; Li WQ; Cao YY; Li Y; Li XH
    Vascul Pharmacol; 2019 Jun; 117():35-44. PubMed ID: 30610955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effects of isorhamnetin on pulmonary arterial hypertension: in vivo and in vitro studies.
    Chang Z; Wang JL; Jing ZC; Ma P; Xu QB; Na JR; Tian J; Ma X; Zhou W; Zhou R
    Phytother Res; 2020 Oct; 34(10):2730-2744. PubMed ID: 32452118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulated bone morphogenetic protein signaling in monocrotaline-induced pulmonary arterial hypertension.
    Morty RE; Nejman B; Kwapiszewska G; Hecker M; Zakrzewicz A; Kouri FM; Peters DM; Dumitrascu R; Seeger W; Knaus P; Schermuly RT; Eickelberg O
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1072-8. PubMed ID: 17347486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulatory effects of Prohibitin 1 on proliferation and apoptosis of pulmonary arterial smooth muscle cells in monocrotaline-induced PAH rats.
    Cao YY; Ba HX; Li Y; Tang SY; Luo ZQ; Li XH
    Life Sci; 2020 Jun; 250():117548. PubMed ID: 32173312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.